Bahl & Gaynor’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,498
Closed -$356K 330
2022
Q2
$356K Sell
6,498
-1,287
-17% -$69.6K ﹤0.01% 296
2022
Q1
$379K Hold
7,785
﹤0.01% 299
2021
Q4
$325K Sell
7,785
-86
-1% -$3.61K ﹤0.01% 306
2021
Q3
$335K Hold
7,871
﹤0.01% 306
2021
Q2
$391K Sell
7,871
-2,257
-22% -$120K ﹤0.01% 302
2021
Q1
$548K Hold
10,128
﹤0.01% 285
2020
Q4
$525K Sell
10,128
-25
-0.2% -$1.19K ﹤0.01% 284
2020
Q3
$443K Hold
10,153
﹤0.01% 287
2020
Q2
$421K Sell
10,153
-1,604
-14% -$61.7K ﹤0.01% 294
2020
Q1
$386K Sell
11,757
-3,269
-22% -$156K ﹤0.01% 294
2019
Q4
$822K Sell
15,026
-806
-5% -$41.4K 0.01% 288
2019
Q3
$761K Buy
15,832
+317
+2% +$15.2K 0.01% 290
2019
Q2
$767K Sell
15,515
-3,102
-17% -$166K 0.01% 289
2019
Q1
$1.09M Sell
18,617
-593
-3% -$32.3K 0.01% 260
2018
Q4
$920K Buy
19,210
+1,069
+6% +$56.4K 0.01% 261
2018
Q3
$1.14M Sell
18,141
-1,614
-8% -$102K 0.01% 261
2018
Q2
$1.28M Sell
19,755
-342
-2% -$22.1K 0.01% 253
2018
Q1
$1.27M Sell
20,097
-843
-4% -$59K 0.01% 254
2017
Q4
$1.49M Buy
20,940
+233
+1% +$15.6K 0.02% 244
2017
Q3
$1.31M Sell
20,707
-1,229
-6% -$77.4K 0.01% 240
2017
Q2
$1.36M Hold
21,936
0.02% 228
2017
Q1
$1.43M Sell
21,936
-870
-4% -$55.7K 0.02% 213
2016
Q4
$1.36M Sell
22,806
-1,363
-6% -$78K 0.02% 213
2016
Q3
$1.39M Sell
24,169
-872
-3% -$50.2K 0.02% 203
2016
Q2
$1.39M Sell
25,041
-3,784
-13% -$196K 0.02% 197
2016
Q1
$1.34M Sell
28,825
-593
-2% -$26.4K 0.02% 198
2015
Q4
$1.4M Sell
29,418
-2,350
-7% -$114K 0.02% 194
2015
Q3
$1.52M Sell
31,768
-2,059
-6% -$104K 0.02% 183
2015
Q2
$1.83M Sell
33,827
-6,010
-15% -$308K 0.02% 182
2015
Q1
$1.86M Sell
39,837
-41,154
-51% -$1.88M 0.03% 183
2014
Q4
$3.3M Buy
+80,991
New +$2.87M 0.05% 139

Other funds holding CDK

Bahl & Gaynor's CDK Position: Q3 2022 in Review

Bahl & Gaynor sold out of CDK Global, Inc. (CDK) in Q3 2022, closing a stake of 6,498 shares — an estimated $356K sold.

Bahl & Gaynor first reported a position in CDK in Q4 2014 and held it in 31 quarters. The position peaked at $3.3M in Q4 2014. 6 funds tracked by Wall St. Rank hold CDK as of Q3 2022.

  • Bahl & Gaynor reported no remaining CDK Global, Inc. position as of Q3 2022 after selling out during the quarter.
  • Bahl & Gaynor sold 6,498 CDK Global, Inc. shares in Q3 2022, an estimated $356K.
  • Bahl & Gaynor first reported a position in CDK Global, Inc. in Q4 2014 and held it in 31 quarters.
  • Bahl & Gaynor's CDK Global, Inc. position peaked at $3.3M in Q4 2014.
  • 6 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q3 2022.

Based on Bahl & Gaynor's 13F filing for Q3 2022, filed 14 Nov 2022.